Existing backer Ligand took part in a series C round that will fund late-stage clinical trials for Palvella Therapeutics' rare genetic disease drug candidates.

The Arm-backed Hopu-Arm Innovation Fund led a series C1 round for the autonmous driving software developer, whose existing backers include Baidu Ventures.

Blue Venture Fund and McKesson Ventures returned to reinvest in the cancer care analysis platform through a round that almost doubled its overall funding.

Philips Health Technology Ventures and UnityPoint Health Ventures have taken part in a $16.7m round for the telehealth technology provider.

Tsinghua-founded autonomous driving software company Idriverplus has secured Hopu-Arm Innovation Fund for its series C1 round.

The call management platform developer has completed a series C round led by DTCP that also featured Swisscom Ventures.

Salesforce Ventures, Swisscom Ventures and returning investor GV helped the computer vision technology provider take its total funding past $120m.

Mitsubishi UFJ Financial Group helped the supply chain finance provider increase a round already featuring several corporates to almost $200m.

OCD drug developer Exscientia bagged $60m in a Novo-led round that also featured Bristol-Myers Squibb and existing corporate investor Evotec.

Novo has led a $60m series C round for University of Dundee’s Exscientia that also attracted Evotec, Bristol-Myers Squibb, and GT Healthcare Capital.